SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-305893
Filing Date
2018-10-24
Accepted
2018-10-24 07:22:50
Documents
148
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d600370d20f.htm 20-F 1707002
2 EX-8.1 d600370dex81.htm EX-8.1 3975
3 EX-12.1 d600370dex121.htm EX-12.1 10410
4 EX-12.2 d600370dex122.htm EX-12.2 10729
5 EX-13.1 d600370dex131.htm EX-13.1 6132
6 EX-23.1 d600370dex231.htm EX-23.1 2035
  Complete submission text file 0001193125-18-305893.txt   10030820

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT kzia-20180630.xml EX-101.INS 2513685
8 XBRL TAXONOMY EXTENSION SCHEMA kzia-20180630.xsd EX-101.SCH 121723
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kzia-20180630_cal.xml EX-101.CAL 130617
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kzia-20180630_def.xml EX-101.DEF 328727
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE kzia-20180630_lab.xml EX-101.LAB 659038
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kzia-20180630_pre.xml EX-101.PRE 538710
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-29962 | Film No.: 181135279
SIC: 2834 Pharmaceutical Preparations